Gynecologic cancer in the elderly

Clinics in Geriatric Medicine

Volumn 13, Issue 2, 1997, Pages 363-379

  Termrungruanglert, W ^a   Kudelka, A P ^a   Edwards, C L ^a   Delclos, L ^a   Verschraegen, C F ^a   Kavanagh, J J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; LEUPRORELIN; MEGESTROL ACETATE; PACLITAXEL; TAMOXIFEN;

AGED; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER HORMONE THERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COMORBIDITY; ENDOMETRIUM CANCER; FEMALE; GASTROINTESTINAL SYMPTOM; GERIATRIC DISORDER; GYNECOLOGIC CANCER; HUMAN; MORBIDITY; NEPHROTOXICITY; OVARY CANCER; PAPANICOLAOU TEST; PATIENT SELECTION; RADIATION INJURY; REVIEW; UTERINE CERVIX CANCER;

EID: 0030995392     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0749-0690(18)30174-5     Document Type: Review

References (77)

1. Ahlgren J.D. Ellison N.M. Bottlieb R.J. Hormonal palliation of chemoresistance ovarian cancer: Three consecutive phase II trial of the Mid-Atlantic Oncology Program J Clin Oncol 11 1993 1957 1968
2. Albert D.S. Green S. Hannigan E.V. Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cylophosphamide: Final report by the Southwest Oncology Group of 3 phase III randomized trial in stage III and IV ovarian cancer J Clin Oncol 10 1992 707 717
3. Alberts D.S. Dahlberg S. Green S.J. Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophophamide versus car-boplatin-cyclophosphamide in stage III (suboptimal) and IV ovarian cancer Cancer 71 1993 618s 627s
4. Averette H.E. Hoskins W. Nguyen H.N. National survery of ovarian carcinoma: A patient care evaluation of the American College of Surgeons Cancer 71 1993 1629s 1638s
5. Balducci L. Lyman G.H. Ershler W.B. Geriatric Oncology 1992 JB Lippincott Philadelphia 151 195
6. Balducci L. Molery K. Pharmacology and organ toxicity of chemotherapy in older patients Oncology 6 1992 62 68
7. Balducci L. Parker M. Sexton W. Pharmacology of antineoplastic agents in the elderly patient Semin Oncol 16 1989 76 84
8. Barly P.S. Lichter A.S. Ash D.K. Consensus Development Conference Statement: Cervical cancer 1996 National Institutes of Health Bethesda MD
9. Bicher A. Sarosy G. Kohn E. Age does not influence taxol dose intensity in recurrent carcinoma of the ovary Cancer 71 1993 594 600
10. Bokhman J.V. Two pathogenetic types of endometrial carcinoma Gynecol Oncol 1993 10 12
11. Bonetti A. Franceschi T. Apostoli P. Cisplatin pharmacokinetics in elderly patients The Drug Monitor 16 1994 477 482
12. Boring C.C. Squires T.S. Tong T. Cancer Statistics, 1996 Cancer 42 1993 19 38
13. Calvert A.H. Newell D.R. Gumbrell L.A. Carboplatin dosage: Prospective evaluation of a simple formula based on renal function J Clin Oncol 7 1989 1748 1756
14. Cornelison T.L. Reed E. Dose intensity analysis of high-dose carboplatin in refractory ovarian carcinoma relative to age Cancer 71 1993 650 655s
15. Costout BS, Persing DH, Apple RJ, et al: Molecular analysis of cervical carcinoma in elderly woman. Proceedings of the Society of Gynecologic Oncology 108A, 1995
16. Delgado G. Stage I.B. Squamous cancer of the cervix: The choice of treatment Obstet Gynecol Surv 33 1978 174
17. Diamandidou E. Kavanagh J.J. Kudelka A.P. Ovarian cancer Pazdur R. Medical Oncology: A Comprehensive Review, ed 2 1996 Publishing, Research, and Representation New York 359 375
18. Edmonson JH, Su J, Krook JE: Treatment of ovarian cancer in elderly woman. Cancer 71:615-61
19. Ferenczy A. Kurman R.J. Carcinoma and other tumors of the cervix Kurman R.J. Blaustein’s Pathology of the Female Genital Tract, ed 4 1994 Springer Verlag New York 279 326
20. Fuchtner C. Manetta A. Walker J.L. Radical hysterectomy in the elderly patient: Analysis of morbidity Am J Obstet Gynecol 166 1992 593
21. Gajewski W.H. Fuller A.F. Ley C.P. Prognostic significance of DNA content in epithelial ovarian cancer Gynecol Oncol 53 1994 5 12
22. Geisler J.P. Geisler H.E. Radical hysterectomy in patients 65 years of age and older Gynecol Oncol 53 1994 208 211
23. Gershenson D.M. Mitchell M.F. Atkinson N. Age contrasts in patients with advanced epithelial ovarian cancer Cancer 71 1993 638 643
24. Goodwins J.S. Hunt W.C. Samet J.M. Determinants of cancer therapy in elderly patients Cancer 72 1993 594 601
25. Gralla R.J. Tyson L.B. Kris M.G. The management of chemotherapy-induced nausea and vomiting Med Clin North Am 71 1987 289
26. Grant P.T. Jeffrey J.F. Fraser R.C. Pelvic radiation therapy for gynecologic malignancy in geriatric patients Gynecol Oncol 33 1989 185 188
27. Griffiths C. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma National Cancer Institute Monographs 41 1975 101
28. Grover S.A. Cook E.F. Adam F. Delayed diagnosis of gynecologic tumors in elderly woman: Relation to national medical practice patterns Am J Med 86 1989 151 157
29. Hacker N.F. Berek J.S. Lagasse L.D. Primary cytoreductive surgery for epithelial ovarian cancer Obstet Gynecol 61 1983 413
30. Hightower R.D. Nguyen H.N. Averette H.E. National survey of ovarian carcinoma IV: Patterns of care and related survival for older patients Cancer 73 1994 377 383
31. Hoffman K. Nekhlyudov L. Deligdisch L. Endometrial carcinoma in elderly woman Gynecol Oncol 58 1995 198 201
32. Holmes FA, Kudelka AP, Kavanagh JJ, et al: Current status of clinical trials with paclitaxel. In Georg GI, Chen TC, Ojima I, et al (eds): Taxane Anticancer Agents: Basic Science and Current Status. American Cancer Society Symposium-in-Print 3:31-57, 1995
33. Kavanagh J.J. Cedillo G.E. Kudelka A.P. Gynecologic cancer in the elderly Cancer Bulletin 47 1995 231 237
34. Kavanagh J.J. Kudelka A.P. Edwards C.L. A randomized cross-over trial of parenteral hydroxurea vs. high dose taxol in cisplatin/carboplatin resistant epithelial ovarian cancer Proceedings of the American Society of Clinical Oncology 12 1993 259
35. Kavanagh J.J. Roberts W. Townsend P. Leuprolide acetate in the treatment of refractory or persistent epithelial ovarian cancer J Clin Oncol 7 1989 115 118
36. Kennedy A.W. Flagg J.S. Webster K.D. Gynecologic cancer in the very elderly Gynecol Oncol 32 1989 49 54
37. Kirschner C.V. DeSerto T.M. Isaacs J.H. Surgical treatment of the elderly patient with gynecologic cancer Surgery Gynecology and Obstetrics 170 1990 379 384
38. Kohn E.C. Sarosy G. Bicher A. Dose-intense Taxol: High response rate in patients with platinum-resistant recurrent ovarian cancer J Natl Cancer Inst 86 1994 18 24
39. Kudelka A.P. Gonzalez de Leon C. Edwards C.L. Tumors of the uterine corpus Pazdur R. Medical Oncology: A Comprehensive Review, ed 2 1996 Publishing, Research, and Representation New York 407 418
40. Kurman R.J. Zaino R.J. Norris H.J. Endometrial carcinoma Kurman R.J. Blaustein’s Pathology of the Female Genital Tract 1994 Springer Verlag New York 439 486
41. Lawton F.G. Hacker N.F. Surgery for invasive gynecologic cancer in the elderly female population Obstet Gynecol 76 1990 287 289
42. Lopez A. Kudelka A.P. Edwards C.L. Carcinoma of the uterine cervix Pazdur R. Medical Oncology: A Comprehensive Review, ed 2 1995 Publishing, Research, and Representation New York 393
43. McGonigle K.F. Lagasse L.D. Karlan B.Y. Ovarian, uterine, and cervical cancer in the elderly woman Clin Geriatric Med 9 1993 115 130
44. McGonigle K.F. Lavey R.S. Juillard G. Complications of pelvic radiation therapy for gynecologic malignancies in elderly women International Journal of Gynecologic Cancer 6 1996 149 155
45. McGowan L. The management of elderly patients with gynecologic cancer Curr Opin Obstet Gynecol 7 1995 53 56
46. McKenna R.J. Clinical aspects of cancer in the elderly: Treatment decision, treatment choices, and follow-up Cancer 74 1994 2107 2117
47. Mandelblatt J. Schechter C. Fahs M. Clinical implications of screening for cervical cancer under Medicare Am J Obstet Gynecol 1991 164 171
48. Mandelblatt J.S. Richart R. Thomas L. Is HPV associated with cervical neoplasia in the elderly? Gynecol Oncol 46 1992 6 12
49. Mandelblatt J.S. Phillips R.N. Cervical cancer: How often-and why-to screen older women Geriatrics 51 1996 45 48
50. Markman M. Lewis J.L. Saigo P. Epithelial ovarian cancer in the elderly: The Memorial Sloan-Kettering Cancer Center Experience Cancer 71 1993 634 637
51. Markman M. Lewis J.L. Saigo P. Impact of age on survival of patients with ovarian cancer Gynecol Oncol 49 1993 236 239
52. Matthews C.M. Morris M. Burke T.W. Pelvic exenteration in the elderly patient Obstetrics and Gynecology 79 1992 773
53. Merino M.J. Jaffe G. Age contrast in ovarian pathology Cancer 71 1993 537s 544s
54. Mitsushashi K.F. Lavey R.S. Juillard G. Complications of pelvic radiation therapy for gynecologic malignancies in elderly women International Journal of Gynecologic Cancer 6 1996 149 155
55. Moore D.H. Ovarian cancer in the elderly patient Oncology 8 1994 21 25
56. Mor V. Allen S.M. Goldberg R.J. Relationship between age at diagnosis and treatments received by cancer patients J Am Geriatr Soc 33 1985 585 589
57. National Cancer Institute: Annual cancer statistics review, including cancer trends: 1950-1985 1989 National Institutes of Health Bethesda
58. Noe C.A. Barry P.P. Healthy aging: Guidelines for cancer screening and immunizations Geriatrics 51 1996 75 83
59. Parazzini F. Negri E. La Vecchia C. Screening practices and invasive cervical cancer risk in different age strata Gynecol Oncol 38 1990 76
60. Park R. Grigsby P. Muss H. Corpus, epithelial tumors Hoskins W. Perez C. Young R. Principles and Practice of Gynecologic Oncology, ed 1 1992 JB Lippincott Philadelphia 663 693
61. Piver M.S. Marchetti D.L. Endometral carcinoma Piver M.S. Mannual of Gynecologic Oncology, ed 1 1989 Williams & Wilkins Baltimore 285 326
62. Ries L.G. Ovarian cancer: Survival and treatment differences by age Cancer 71 1993 524s 529s
63. Ries L.G. Hankey B.F. Miller B.A. Cancer Statistics Review 1973-1988 1991 National Institutes of Health, National Cancer Institute Bethesda 2789
64. Riggs J.E. Rising ovarian cancer mortality in the elderly: A manifestation of differential survival Gynecol Oncol 58 1995 64 67
65. Silliman R.A. Guadagnoli E. Weitberg A.B. Age as a predictor of diagnostic and initial treatment intensity in newly diagnosed breast cancer patients J Gerontol 44 1989 46M 50M
66. Silverberg E. Boring C.C. Squires T. Cancer statistics CA Cancer J Clin 43 1993 18 39
67. Slamon D.J. Godolphin W. Jones L.A. Studies of HER-2/neu proto-oncogene in human breast an ovarian cancer Science 244 1989 707 712
68. Taylor A.E. Wiltshaw C. Gore M.E. Long-term follow up of the first randomized study of cisplatin versus carboplatin for advanced epithelial ovarian cancer J Clin Oncol 12 1994 2066 2070
69. The Surveillance Program, Division of Cancer Preventive and Control Cancer Statistics Review, 1973-1987 1988 National Cancer Institute Washington DC Publication No. 90-2789
70. Thigpen J.T. Blessing J.A. Ball H. Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: A gynecologic oncology group study J Clin Oncol 12 1994 1748 1753
71. Thigpen T. Brady M.F. Omura G.A. Age as a prognostic factor in ovarian carcinoma Cancer 71 1993 606s 614s
72. Walsh J.M. Cancer screening in older adults West J Med 156 1992 495 500
73. Weinrich S. Coker A.L. Weinrich M. Predictors of Pap smear screening in socioeco-nomically disadvantaged elderly woman J Am Geriatr Soc 43 1995 267 270
74. Yancik R. Ries L.G. Yates J.W. Ovarian cancer in the elderly: An analysis of surveillance, epidemiology, and end results program data Am J Obstet Gynecol 154 1986 647 693
75. Yancik R. Ries L. Cancer in the aged: An epidemiological perspective on treatment issues Cancer 68 1991 2502s 2511s
76. Yancik R. Ovarian cancer: Age contrasts in incidence, histology, disease stage at diagnosis, and mortality Cancer 71 1993 517s 523s
77. Zaheer W. Lichtman S.M. Semarco L. The use of Taxol in elderly patients Proceedings of the American Society of Clinical Oncology 13 1994 A1518